Core Viewpoint - Shenzhen Guanghua Weiye Co., Ltd. has initiated the IPO counseling record with the Shenzhen Securities Regulatory Bureau, aiming to list on the Beijing Stock Exchange, with Shenwan Hongyuan Securities as the counseling institution [1][2]. Company Overview - Guanghua Weiye was established on May 29, 2002, with a registered capital of 57.6 million yuan, and is engaged in the production, operation, and service provision of 3D printing materials and environmentally friendly biological materials [2][4]. - The controlling shareholder is Yida Biological New Technology (Shenzhen) Limited Partnership, holding a direct stake of 33.05% [1][4]. Financial Performance - In the first half of 2025, the company achieved operating revenue of 344 million yuan, an increase of 41.43% compared to the same period last year, and a net profit of 25.45 million yuan, up 46.88% year-on-year [2]. - For the year 2024, the company reported operating revenue of 544 million yuan, a year-on-year increase of 29.85%, but a net profit of 24.18 million yuan, which represents a decline of 45.16% compared to the previous year [2]. Shareholder Information - Yang Yixu, the legal representative, directly holds 19.91% of the company’s shares and indirectly controls 33.05% through Yida Biological, totaling 52.96% of the shares, making him the actual controller of the company [4].

Group 1 - The core viewpoint of the news is that Shenzhen Guanghua Weiye Co., Ltd. has initiated the IPO counseling record with the Shenzhen Securities Regulatory Bureau, aiming to list on the Beijing Stock Exchange, with Shenwan Hongyuan Securities as the counseling institution [1] - Guanghua Weiye was established on May 29, 2002, with a registered capital of 57.6 million yuan, and is involved in the production, operation, and service provision of 3D printing materials and environmentally friendly biological materials [2] - The company’s major products and services include 3D printing products and environmentally friendly biological materials [2] Group 2 - In the first half of 2025, the company achieved operating revenue of 344 million yuan, an increase of 41.43% compared to the same period last year, and a net profit of 25.45 million yuan, up 46.88% year-on-year [2] - In 2024, the company reported operating revenue of 544 million yuan, a year-on-year increase of 29.85%, while net profit was 24.18 million yuan, a decrease of 45.16% compared to the previous year [2] - The controlling shareholder of Guanghua Weiye is Yida Biological New Technology (Shenzhen) Limited Partnership, holding a direct stake of 33.05%, while Yang Yixu holds 19.91% directly and controls a total of 52.96% of the shares, making him the actual controller of the company [4]